Add time:08/30/2019         Source:sciencedirect.com

Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine (cas 136232-82-1) is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for use of illicit buprenorphine in the United States. Findings from the 17 included studies suggest the majority of study participants using illicit buprenorphine do so for reasons related to misuse (to manage opioid withdrawal symptoms or achieve or maintain abstinence from other opioids). A smaller percentage of study respondents reported using buprenorphine for reasons related to abuse (to get high). There appears to be a gap between need for buprenorphine and access to adequate treatment. Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD.

We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers